INOD Innodata

DGAP-News: Reliance on News Releases has Increased During COVID-19 Crisis, Finds Special Report From Agility PR Solutions

DGAP-News: Agility PR Solutions / Key word(s): Miscellaneous
Reliance on News Releases has Increased During COVID-19 Crisis, Finds Special Report From Agility PR Solutions

28.05.2020 / 17:26
The issuer is solely responsible for the content of this announcement.


OTTAWA, CANADA / ACCESSWIRE / May 28, 2020 / A research report released today by Agility PR Solutions, a subsidiary of Innodata Inc. (NASDAQ:INOD), shows an increase in reliance on news releases as a communication method to disseminate information during the COVID-19 crisis.

"We've seen a substantial increase since January in the number of news releases sent by our clients and the amount of PR outreach targeted at journalists," says Martin Lyster, CEO of Agility PR Solutions. "We've also seen a shift in what our clients are communicating about. Currently, just over half of all the news releases our clients are sending are related to the coronavirus."

The report summarizes client use of Agility PR Solutions' distribution services, which include direct targeting emails and newswire releases. The analysis focuses on the first four months of 2020. Some of the report's findings include:

  • A 30 percent increase in news releases sent by clients per working day in March and April
  • A 60 percent increase in the outreach targeted to journalists
  • The industries that sent the highest percentage of COVID-19 related news releases were health and pharmaceuticals, government and government agencies, and education

In times of crisis, it's especially important for organizations to convey key messaging and provide a prudent response. Cogent communication through news releases can help a brand maintain its reputation and retain customers.

"Our data continues to show month over month increases in news release volumes around COVID-19," says Lyster. "Our clients know the benefit of disseminating information quickly in critical situations. News release distribution services are an effective and affordable PR tool, especially right now."

The report from Agility PR Solutions includes discoveries around news release usage, best practices for writing a press release, and tips on what's capturing media attention during the current pandemic. Download the full report: .

About Agility PR Solutions

Agility PR Solutions, a subsidiary of INNODATA INC. (NASDAQ:INOD), provides powerful yet intuitive media outreach, monitoring, and measurement solutions for tomorrow's communicators. Since 2003, clients have trusted Agility tools and services to help them discover and connect with media influencers, amplify messages, monitor coverage, and measure the impact of their public relations efforts. Whether Agility does it for you or helps you do it yourself, Agility's patented monitoring technology and a team of media analysts can help you glean the insights that will help your organization flourish. Learn more at .

Contact:

Lynn Gayowski
Director of Marketing

SOURCE: Agility PR Solutions


News Source: Issuer Direct


28.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Agility PR Solutions
United States
ISIN: US4576422053
EQS News ID: 1058293

 
End of News DGAP News Service

1058293  28.05.2020 

fncls.ssp?fn=show_t_gif&application_id=1058293&application_name=news&site_id=research_pool
EN
28/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Innodata

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
HURN HURON CONSULTING GROUP INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BZH BEAZER HOMES USA INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
INOD INNODATA
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
CVCO CAVCO INDUSTRIES INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
STX SEAGATE TECHNOLOGY HLDGS PLC
ATXS ASTRIA THERAPEUTICS INC
GFS GLOBALFOUNDRIES INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
Anish Jog ... (+4)
  • Anish Jog
  • Daniel Ives
  • Sam Brandeis
  • Steven Wahrhaftig

2Q25 Earnings Solid: Big Deal Timings Skew Strong Foundational Growth

FY2Q25 (June) Key Measures & FY25 GuidanceINOD recently won several new projects with its largest customer and have others in pipeline that are not yet included in their forecast. Several of these new projects are under the second SOW which provides greater access to an even larger generative A

ResearchPool Subscriptions

Get the most out of your insights

Get in touch